In a nutshell One injection of zilebesiran every six months could replace daily blood pressure pills for some patients Blood ...

Accumulating evidence has made it clear that not only does the renin–angiotensin–aldosterone system (RAAS) exist in the circulation where it is driven by renal renin, but it is also active in ...

Researchers have found that prescribing guideline-directed medical treatment (GDMT), regardless of the number of medications, ...

The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene ...

The addition of SGLT2i to RAASi was associated with lower hyperkalemia risk among patients with diabetes, heart failure, or CKD.

Researchers have found that prescribing guideline-directed medical treatment (GDMT), regardless of the number of medications, ...

Researchers have found that prescribing guideline-directed medical treatment (GDMT), regardless of the number of medications, can improve survival rates in patients 90 years of age and older following ...

Overweight children are more vulnerable to early-onset hypertension. Childhood obesity is driving a rise in high blood ...

Renal hypoperfusion occurs as a result of reduced cardiac output, resulting in the activation of the renin–angiotensin–aldosterone system, which compensates for the hypoperfusion. However ...

Higher serum sodium levels, even within the normal range, are linked to increased risk of developing hypertension and heart ...

SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

physicians must be aware of clinical circumstances that may promote the development of hyperkalemia The renin–angiotensin–aldosterone system (RAAS) has a pathogenetic role in several edematous ...